← Eichor
Study identifier: NCT05102929 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia

Condition: Schizophrenia  ·  Sponsor: Fabio Ferrarelli

PhaseNA
Planned participants75
Who can joinAll sexes, 18 Years to 40 Years
Healthy volunteersNo

About this study

This study will investigate the effects of intermittent Theta Burst Stimulation (iTBS) on natural oscillatory frequency of the dorsolateral prefrontal cortex (DLPFC) and working memory in early-course schizophrenia (EC-SCZ). Transcranial magnetic stimulation (TMS) will be used to evoke oscillatory activity, and EEG will record the responses of EC-SCZ participants. A working memory task will also be incorporated in order to determine how DLPFC natural frequency (NF) is related to working memory performance. iTBS (active or sham) will be administered, then the oscillatory activity of DLPFC and working memory performance will be reassessed. The overarching goal is to determine whether iTBS can acutely enhance the oscillatory activity of the DLPFC and to evaluate the relationship between changes in the DLPFC and working memory performance.

This description comes directly from the study's public registry record.

Talk to the study team

Sabine Janssen  ·  412-246-6114  ·  janssensa@upmc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of PittsburghPittsburgh, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05102929